Interleukin (IL)-25 suppresses IL-22 induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway

Hong Ki Min(Konkuk University), Kyoung‐Woon Kim(Konkuk University)
Research Square
December 20, 2019
10.21203/rs.2.19355/v1
Cited by 0

Related Papers

Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor κB-dependent pathway in patients with rheumatoid arthritis
|Arthritis Research & Therapy|2004|112
Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease
|Stem Cell Research & Therapy|2015|48
The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation <i>in vitro</i> and <i>in vivo</i> in kidney transplant recipients
|Immunology|2014|46
Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway
|Arthritis Research & Therapy|2020|36
Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance data
|Epidemiology and Health|2023|23